Is DARPA implantable microchip to detect COVID-19 the mark of the beast? (Photo credit: Shutterstock.com / Gorodenkoff) The Defense Advanced Research Projects Agency, commonly referred to as DARPA, was established during the Cold War more than 60 years ago. For 60 years, DARPA has maintained and advanced the mission of making “pivotal investments in breakthrough technologies for national security.” Many are familiar with their human and animal-like robots, but recently, they have taken on another mission that involves being prepared for future pandemics like COVID 19. Recently, the organization has invested more in this area. DARPA’s Pandemic Prevention Platform (P3) program, which started in 2017, looks at finding, describing, producing, testing, and the delivery of effectual DNA — and RNA — encoded medical technologies to fight infectious disease. According to its website, the technological aspects of this research were developed by the organization under the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program. The goal is to implement technology that will be able to offer the body bioengineered instructions on how to produce protective antibodies against a given threat when required.